COMMUNIQUÉS West-GlobeNewswire

VALNEVA Déclaration d’actions et de droits de vote : 31 janvier 2026
11/02/2026
VALNEVA Déclaration d’actions et de droits de vote 31 janvier 2026 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : Îlot [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions – JANVIER 2026
11/02/2026
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH
11/02/2026
CHEYENNE, Wyo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX) (“CS Group” or the “Company”), a medical technology and hygiene solutions company, today announced the appointment of Shah Teelani [...]
EssilorLuxottica: Le Conseil d’administration d’EssilorLuxottica propose la nomination de huit administrateurs et administratrices
11/02/2026
Le Conseil d’administration d’EssilorLuxottica propose la nomination de huit administrateurs et administratrices Paris, France (11 février 2026 – 18h00) – Réuni aujourd’hui, le Conseil d’administration d’ [...]
Sanofi: Information concerning the total number of voting rights and shares – January 2026
11/02/2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
VALNEVA Declaration of shares and voting rights: January 31, 2026
11/02/2026
VALNEVA Declaration of shares and voting rights January 31, 2026 __________________________________________________________________________________________ Company name: VALNEVA Registered office: Îlot Saint-Joseph [...]
Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies
11/02/2026
CHICAGO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced the expansion of its digital [...]
EssilorLuxottica: EssilorLuxottica Board of Directors Proposes Renewal of Eight Directors
11/02/2026
EssilorLuxottica Board of Directors Proposes Renewal of Eight Directors Paris, France (11 February 2026 – 6:00pm) – During its meeting today, EssilorLuxottica Board of Directors decided to propose to the Shareholders’ [...]
Alvotech Announces Increase in Number of Own Shares
11/02/2026
REYKJAVIK, ICELAND (February 11, 2026) — Alvotech (NASDAQ: ALVO) (the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, has increased [...]
Bay Area Lyme Foundation Highlights Research Leadership and Momentum in Tick-Borne Disease, Names New Executive Director
11/02/2026
Milestones include FDA-cleared diagnostics enabled by Lyme Disease Biobank, the launch of Bay Area Lyme Ventures, and 10 years since Lyme Disease Biobank provided its first samples, advancing the field PORTOLA VALLEY, [...]
EssilorLuxottica: Résultats T4 et annuels 2025 - Hausse de +18,4 % du chiffre d'affaires au T4 et de +11,2 % sur l'exercice. Marge opérationnelle ajustée à 16,0 % sur l'exercice
11/02/2026
Hausse de +18,4 % du chiffre d'affaires 1 au T4 et de +11,2 % sur l'exercice Marge opérationnelle ajustée 1,2 à 16,0 % sur l'exercice Chiffre d’affaires annuel du Groupe à 28 491 millions d’euros, +11,2 % à taux de [...]
Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership
11/02/2026
MELBOURNE, Australia and LAS VEGAS, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq”) and Healthy Extracts™ Inc. (“Healthy Extracts”) today announced the signing of a Memorandum of Understanding (“MoU”) [...]
24/7 Market News - Not Magic, Just Science: Kraig Labs’ Transgenic Silkworms Make History at Scale
11/02/2026
Kraig Labs Cracks the Spider Silk Code DENVER, Feb. 11, 2026 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that [...]
INVO Fertility Announces Patent Issuance for Modified INVOcell® Device
11/02/2026
New patent extends intellectual property protection on the Company’s INVOcell device through 2040 SARASOTA, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a [...]
Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)
11/02/2026
Robust SENTI-202 clinical data presented at ASH 2025 demonstrated deep, MRD-negative, durable complete remissions and a favorable safety profile Company planning for rapid advancement of SENTI-202 into R/R AML pivotal [...]
HealthEdge® Achieves HITRUST Risk-based, 2-year Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements
11/02/2026
FRISCO, Texas and BOSTON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- HealthEdge ® , the technology and services company powering health plans’ most important value streams, today announced that it has achieved HITRUST r2 [...]
AIM ImmunoTech Announces Commencement of Rights Offering
11/02/2026
OCALA, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of its lead [...]
Outlook Therapeutics Submits Type A Meeting Request to FDA Following Complete Response Letter
11/02/2026
ISELIN, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, [...]
Amplia Therapeutics Announces Opening of US Sites for Amplicity Pancreatic Cancer Trial
11/02/2026
Melbourne, Australia, Feb. 11, 2026 (GLOBE NEWSWIRE) -- HIGHLIGHTS Two US-based sites have completed trial initiation activities for the AMPLICITY trial in pancreatic cancer These sites join the two Australian sites [...]

Pages